The African Development Bank is establishing a foundation with the aim of spending at least $3 billion over the next decade to boost Africa’s access to technologies needed to make medicines, vaccines, and other pharmaceutical products. The bank’s board approved the establishment of the African Pharmaceutical Technology Foundation with an eye to towards creating what […] Continue reading ->
With a 77% increase in new monkeypox cases in the past week, the World Health Organization’s (WHO) Emergency Committee is increasingly likely to declare the outbreak a public health emergency of international concern (PHEIC) when it reconvenes on or before 18 July. By Thursday, 59 countries had reported monkeypox cases, with Spain (1804 cases), UK […] Continue reading ->
French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading ->
The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading ->
Within a week of overturning the constitutional right to an abortion, the United States Supreme Court has now dealt a severe blow to the nation’s ability to strictly regulate and reduce carbon dioxide emissions from power plants that contribute to global warming, with escalating impacts on health and well-being. US President Joe Biden described Thursday’s […] Continue reading ->